APOE in the bullseye of neurodegenerative diseases: impact of the APOE genotype in Alzheimer's disease pathology and brain diseases

R Fernández-Calle, SC Konings… - Molecular …, 2022 - Springer
ApoE is the major lipid and cholesterol carrier in the CNS. There are three major human
polymorphisms, apoE2, apoE3, and apoE4, and the genetic expression of APOE4 is one of …

[HTML][HTML] Neuropathological evidence of body-first vs. brain-first Lewy body disease

P Borghammer, J Horsager, K Andersen… - Neurobiology of …, 2021 - Elsevier
Aggregation of alpha-synuclein into inclusion bodies, termed Lewy pathology, is a defining
feature of Parkinson's disease (PD) and Dementia with Lewy bodies (DLB). In the majority of …

SARS-CoV-2 drives NLRP3 inflammasome activation in human microglia through spike protein

EA Albornoz, AA Amarilla, N Modhiran, S Parker… - Molecular …, 2023 - nature.com
Abstract Coronavirus disease-2019 (COVID-19) is primarily a respiratory disease, however,
an increasing number of reports indicate that SARS-CoV-2 infection can also cause severe …

Conformational strains of pathogenic amyloid proteins in neurodegenerative diseases

D Li, C Liu - Nature Reviews Neuroscience, 2022 - nature.com
Amyloid proteins, which are considered 'villains' in many neurodegenerative diseases, form
enigmatic pathological strains that underlie disease pathogenesis and progression. Recent …

Motor and non-motor circuit disturbances in early Parkinson disease: which happens first?

J Blesa, G Foffani, B Dehay, E Bezard… - Nature Reviews …, 2022 - nature.com
For the last two decades, pathogenic concepts in Parkinson disease (PD) have revolved
around the toxicity and spread of α-synuclein. Thus, α-synuclein would follow caudo-rostral …

Protein interaction networks in neurodegenerative diseases: From physiological function to aggregation

G Calabrese, C Molzahn, T Mayor - Journal of Biological Chemistry, 2022 - ASBMB
The accumulation of protein inclusions is linked to many neurodegenerative diseases that
typically develop in older individuals, due to a combination of genetic and environmental …

O-GlcNAc forces an α-synuclein amyloid strain with notably diminished seeding and pathology

AT Balana, AL Mahul-Mellier, BA Nguyen… - Nature chemical …, 2024 - nature.com
Amyloid-forming proteins such α-synuclein and tau, which are implicated in Alzheimer's and
Parkinson's disease, can form different fibril structures or strains with distinct toxic properties …

Brain-targeted biomimetic nanodecoys with neuroprotective effects for precise therapy of Parkinson's disease

Y Liu, J Luo, Y Liu, W Liu, G Yu, Y Huang… - ACS Central …, 2022 - ACS Publications
Parkinson's disease (PD) is a neurodegenerative disorder characterized by the gradual loss
of dopaminergic neurons in the substantia nigra and the accumulation of α-synuclein …

PARK Genes Link Mitochondrial Dysfunction and Alpha-Synuclein Pathology in Sporadic Parkinson's Disease

W Li, YH Fu, GM Halliday, CM Sue - Frontiers in Cell and …, 2021 - frontiersin.org
Parkinson's disease (PD) is an age-related neurodegenerative disorder affecting millions of
people worldwide. The disease is characterized by the progressive loss of dopaminergic …

[HTML][HTML] Exosomes, autophagy and ER stress pathways in human diseases: Cross-regulation and therapeutic approaches

B Jahangiri, AK Saei, PO Obi, N Asghari… - … et Biophysica Acta (BBA …, 2022 - Elsevier
Exosomal release pathway and autophagy together maintain homeostasis and survival of
cells under stressful conditions. Autophagy is a catabolic process through which cell entities …